Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
- PMID: 18219319
- DOI: 10.1038/sj.cdd.4402309
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
Abstract
MDM2, a ubiquitin E3-ligase of the RING family, has a key role in regulating p53 abundance. During normal non-stress conditions p53 is targeted for degradation by MDM2. MDM2 can also target itself and MDMX for degradation. MDMX is closely related to MDM2 but the RING domain of MDMX does not possess intrinsic E3-ligase activity. Instead, MDMX regulates p53 abundance by modulating the levels and activity of MDM2. Dimerization, mediated by the conserved C-terminal RING domains of both MDM2 and MDMX, is critical to this activity. Here we report the crystal structure of the MDM2/MDMX RING domain heterodimer and map residues required for functional interaction with the E2 (UbcH5b). In both MDM2 and MDMX residues C-terminal to the RING domain have a key role in dimer formation. In addition we show that these residues are part of an extended surface that is essential for ubiquitylation in trans. This study provides a molecular basis for understanding how heterodimer formation leads to stabilization of MDM2, yet degradation of p53, and suggests novel targets for therapeutic intervention.
Similar articles
-
Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.Cell Cycle. 2012 Mar 1;11(5):953-62. doi: 10.4161/cc.11.5.19445. Epub 2012 Mar 1. Cell Cycle. 2012. PMID: 22333590 Free PMC article.
-
A site-directed mutagenesis study of the MdmX RING domain.Biochem Biophys Res Commun. 2014 May 16;447(4):696-701. doi: 10.1016/j.bbrc.2014.04.065. Epub 2014 Apr 19. Biochem Biophys Res Commun. 2014. PMID: 24755078
-
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.Biochemistry. 2003 Mar 4;42(8):2291-9. doi: 10.1021/bi0271291. Biochemistry. 2003. PMID: 12600196
-
p53 regulation: teamwork between RING domains of Mdm2 and MdmX.Cell Cycle. 2011 Dec 15;10(24):4225-9. doi: 10.4161/cc.10.24.18662. Epub 2011 Dec 15. Cell Cycle. 2011. PMID: 22134240 Review.
-
Mdm2 and MdmX partner to regulate p53.FEBS Lett. 2012 May 21;586(10):1390-6. doi: 10.1016/j.febslet.2012.02.049. Epub 2012 Mar 8. FEBS Lett. 2012. PMID: 22673503 Review.
Cited by
-
Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.Oncogene. 2012 Nov 8;31(45):4789-97. doi: 10.1038/onc.2011.625. Epub 2012 Jan 23. Oncogene. 2012. PMID: 22266850 Free PMC article.
-
Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops.Genes Cancer. 2012 Mar;3(3-4):291-7. doi: 10.1177/1947601912454140. Genes Cancer. 2012. PMID: 23150762 Free PMC article.
-
The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization.J Biol Chem. 2015 May 15;290(20):12941-50. doi: 10.1074/jbc.M115.644435. Epub 2015 Mar 25. J Biol Chem. 2015. PMID: 25809483 Free PMC article.
-
Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.Cell Cycle. 2012 Mar 1;11(5):953-62. doi: 10.4161/cc.11.5.19445. Epub 2012 Mar 1. Cell Cycle. 2012. PMID: 22333590 Free PMC article.
-
MDM2-MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonance.Int J Nanomedicine. 2016 Aug 30;11:4221-9. doi: 10.2147/IJN.S114705. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27621617 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
